interesting new product from ebio, page-7

Hi Phil,
I just took the highest figure a adorite guessed (10% of 32 mill) and divided by the percentage of hype (a factor of approx 6). :)
Then cross checked with upfront payment 100K and found that total revenue for ebio was 70 mill a year and then a reliable estimate that ebio had 16% of a 200 mill market for all it's Flow cymetry products and then took into account the president of Ebio stating that it intended to use missago for it's FlowCytomix™ Bead-based immunoassays and I generously asumed tthat that accounts for about a third of their 32 mill revenue.
so %5 of 10 million , I think is generous assuming that they wont have missngo on all of those intended products immediately.